>

PARABOLIC DRUGS fundamental analysis

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
The Drivers Module shows relationships between PARABOLIC DRUGS's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of PARABOLIC DRUGS over time as well as its relative position and ranking within its peers. Check out Your Equity Center.

PARABOLIC DRUGS Net Income vs. Price to Earning Fundamental Analysis

PARABOLIC DRUGS is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in net income category among related companies .
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
PARABOLIC DRUGS 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
=
(0.44) 
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Net income is the profit of a company for the reporting period which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most watched numbers by money managers as well as individual investors.
PARABOLIC DRUGS 
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
=
(1.08 B)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin which measures income as a percentage of sales.

PARABOLIC DRUGS Net Income Comparison

PARABOLIC DRUGS Fundamental Comparison